SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-14
👔
TENAX THERAPEUTICS, INC.
@TENX_InsiderForm 4 Filing: Giordano Christopher Thomas Exercises Options for $51,267.231 of $TENX
OPTION EXERCISE
⚡ MATERIALITY: 5/10
corporate issuer
TENAX THERAPEUTICS, INC.
Ticker: $TENX
Transaction Value
$51,267.231
Price/Share: $5.88
transaction date
2026-07-13
Shares: 8,719
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Giordano Christopher Thomas, holds the title of CEO at TENAX THERAPEUTICS, INC..
On 2026-07-13, the insider transacted 8,719 shares.The shares were transacted at a weighted average price of $5.88 per share, resulting in a total market-relevant value of $51,267.231.
Executive Summary Summary
Giordano Christopher Thomas (CEO) exercised options for $51K of $TENX
Post-Transaction Position: 11,324 shares
SEC Accession No: 0001193125-26-303600 (CIK: 1871714)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.